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eal-time voltammetry measurements from cracked
PC12 cells were used to analyze the role of synap-
 
totagmin–SNARE interactions during Ca
 
2
 
 
 
-triggered
exocytosis. The isolated C2A domain of synaptotagmin I
neither binds SNAREs nor inhibits norepinephrine secretion.
In contrast, two C2 domains in tandem (either C2A-C2B
or C2A-C2A) bind strongly to SNAREs, displace native
synaptotagmin from SNARE complexes, and rapidly inhibit
 
exocytosis. The tandem C2 domains of synaptotagmin
 
cooperate via a novel mechanism in which the disruptive
R
 
effects of Ca
 
2
 
 
 
 ligand mutations in one C2 domain can
be partially alleviated by the presence of an adjacent C2
 
domain. Complete disruption of Ca
 
2
 
 
 
-triggered membrane
and target membrane SNARE interactions required simul-
taneous neutralization of Ca
 
2
 
 
 
 ligands in both C2 domains
of the protein. We conclude that synaptotagmin–SNARE
 
interactions regulate membrane fusion and that coopera-
tion between synaptotagmin’s C2 domains is crucial to
its function.
 
Introduction
 
Recent advances indicate that intracellular membrane fu-
sion is catalyzed by SNARE complexes (Söllner et al., 1993;
Weber et al., 1998). In neurons, the SNARE complex is
composed of the synaptic vesicle protein synaptobrevin/
VAMP and the plasma membrane proteins syntaxin and
the synaptosome-associated protein of 25 kD (SNAP-25)*
 
(Söllner et al., 1993). These proteins assemble to form
a four-helix bundle that closely juxtaposes the vesicle
and target membranes (Sutton et al., 1998). Reconstitu-
tion experiments provide direct evidence that assembly of
SNARE complexes is sufficient to catalyze membrane fusion
(Weber et al., 1998). However, fusion mediated by purified
 
SNAREs exhibits slow kinetics and is not regulated by Ca
 
2
 
 
 
.
In contrast, exocytosis from neurons and other cell types is
rapid and strictly regulated by Ca
 
2
 
 
 
 (Burgoyne and Morgan,
1998; Augustine, 2001).
The Ca
 
2
 
 
 
-binding synaptic vesicle protein synaptotagmin
I (syt) has been proposed to serve as the Ca
 
2
 
 
 
 sensor that
regulates secretion (Brose et al., 1992; Geppert et al., 1994;
Littleton et al., 1994, 2001; Fernández-Chacón et al.,
2001), although this role has been debated (DiAntonio and
Schwarz, 1994). Syt I spans the vesicle membrane once and
possesses a large cytoplasmic domain largely composed of
two C2 domains (Perin et al., 1990). The membrane proxi-
mal C2 domain, C2A, penetrates lipid bilayers in response
to Ca
 
2
 
 
 
 (Davis et al., 1999), and the membrane distal C2
domain, C2B, mediates Ca
 
2
 
 
 
-triggered oligomerization of
syt I (Desai et al., 2000). Interestingly, both C2 domains
synergize to directly interact with the target membrane
SNAREs (t-SNAREs) syntaxin and SNAP-25, and this in-
teraction can occur at all stages of SNARE complex assem-
bly (for review see Augustine, 2001). These findings raise
the possibility that syt could regulate SNARE catalyzed
membrane fusion in response to binding Ca
 
2
 
 
 
.
This study investigates the biochemical and functional role
of tandem C2 domains for complex formation with t-SNAREs
and membranes. Our data suggest that syt–SNARE interac-
 
tions are critical for Ca
 
2
 
 
 
-triggered exocytosis and that the tan-
dem C2 domains of syt exhibit unique properties and possess
partially redundant Ca
 
2
 
 
 
 binding sites.
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Results and discussion
 
For these studies, PC12 cells were “cracked open” to gain di-
rect access to the fusion machinery that mediates release of
norepinephrine (NE) from large dense core vesicles (LD-
CVs). Upon addition of Ca
 
2
 
 
 
, released NE was detected in
real time via rotating disc electrode (RDE) voltammetry
(Fig. 1 A). The timecourse of NE release in response to 100
 
 
 
M Ca
 
2
 
 
 
 is shown in Fig. 1 B (top); 1 mM Mg
 
2
 
 
 
 failed to
trigger release. The release kinetics are not limited by the dif-
fusion of Ca
 
2
 
 
 
 or the response time of the instrument as
shown by the immediate electrode response upon addition
of NE to the assay system. Ca
 
2
 
 
 
-triggered release curves were
fitted with a single exponential function to calculate the
time constant (
 
 
 
) for release at different Ca
 
2
 
 
 
 concentra-
tions. This made it possible to determine the Ca
 
2
 
 
 
 depen-
dence of the rate of exocytosis from these cells. In Fig. 1 B
(bottom), the reciprocal of the time constant is plotted ver-
sus the free Ca
 
2
 
 
 
, as measured with a Ca
 
2
 
 
 
 electrode, and
the [Ca
 
2
 
 
 
]
 
1/2
 
 was 19.7 
 
 
 
 4.7 
 
 
 
M. This value is similar to re-
sults obtained using photolysis of caged Ca
 
2
 
 
 
 in intact pitu-
itary melanotrophs and chromaffin cells (for review see Bur-
goyne and Morgan, 1998) and is somewhat higher than
previous estimates of release from permeabilized PC12 cells
that were based on static secretion measurements (
 
 
 
10 
 
 
 
M;
Klenchin et al., 1998). These data indicate that LDCV exo-
cytosis in multiple cell types is regulated via Ca
 
2
 
 
 
 sensors
with similar properties.
 
Synaptic transmission has a steep temperature dependence
that reflects activation energies of presynaptic voltage-acti-
vated Ca
 
2
 
 
 
 channels, the fusion machinery, and postsynap-
tic receptors (Sabatini and Regehr, 1996). The RDE cracked
cell assay eliminates the contributions from channels and
postsynaptic receptors. In addition, a recent study indicates
that release from cracked PC12 cells reflects the exocytosis of
predocked LDCVs (Chen et al., 2001). Therefore, we used
the RDE cracked cell assay to selectively examine the tem-
perature dependence of the Ca
 
2
 
 
 
-triggered release process
(Fig. 1, C and D). Exocytosis was blocked at temperatures at
or below 15
 
 
 
C and was maximal by 22.5
 
 
 
C (Fig. 1 C). An
Arrhenius plot indicated that release exhibits an activation
energy of 108 
 
 
 
 7 kJ/mole (Fig. 1 D). This value is similar
to the activation energies for viral-mediated fusion, GTP
 
 
 
S-
driven fusion in mast cells, and values obtained using model
systems (Lee and Lentz, 1998), suggesting that all of these
fusion reactions involve common or similar mechanisms.
We next used this assay to examine the function of syt
during exocytosis. Previously, we reported that the cyto-
plasmic domain of recombinant syt I (C2A-C2B) inhibits
secretion from cracked PC12 cells (Desai et al., 2000)
and proposed that it functions as a dominant negative re-
agent that blocks homo- and heterooligomerization of syt
isoforms in response to Ca
 
2
 
 
 
. This effect is apparent in
the RDE secretion assay and serves as a reference point
for the new constructs described below (Fig. 2 A). Re-
Figure 1. Ca
2  and temperature depen-
dence of NE release from cracked PC12 
cells measured with a real-time assay. 
(A) Schematic diagram of the instrument 
used to measure exocytosis by RDE
voltammetry (modified from Earles and 
Schenk, 1998). The Ag/AgCl reference 
(ref) and platinum auxiliary (aux) elec-
trodes are indicated. (B) Ca
2  but not 
Mg
2  releases NE (top; arrow indicates 
the time of addition). Immediate 
response upon addition of NE to cell-free 
buffer demonstrates that Ca
2 -triggered 
release is monitored in real time. Ca
2 -
dependent release profiles fit single 
exponential functions; 1/  (    time con-
stant) was plotted versus [Ca
2 ]free 
(bottom), the [Ca
2 ]1/2 was 19.7   4.7 
 M (n   3–6,   SD);     45 s at saturat-
ing [Ca
2 ]. (C) Temperature dependence 
of exocytosis. NE was measured 80 s after 
addition of 100  M Ca
2 . (D) Arrhenius 
plot yields an activation energy (Ea) of 
108   7 kJ/mole (n   3,   SD). 
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verse genetic and biochemical studies by Littleton et al.
(2001) revealed that a mutation that disrupts the Ca
 
2
 
 
 
-
triggered oligomerization activity of syt I inhibits the
ability of docked synaptic vesicles to fuse in response to
stimulation.
Mutations within the C2B region of the C2A-C2B con-
struct (K326,327A; designated C2A-C2B*) largely abro-
gated its inhibitory activity in the cracked cell assay; how-
ever, we noted that the mutant version retained some
activity, albeit at higher concentrations than C2A-C2B (2–5
 
 
 
M; Fig. 1 A; Desai et al., 2000). These findings suggested
 
that the K326,327A mutation may have unmasked a second
mode of inhibition mediated by a relatively low affinity
C2A-C2B*–target protein interaction. C2A-C2B* failed to
bind known syt binding proteins, including other copies of
syt, SV2, and AP-2 (Fig. 2 D), but retained t-SNARE bind-
ing activity (Fig. 2 B and Fig. 3 B). As shown in Fig. 2 B,
C2A-C2B* bound SNAP-25 with an affinity that closely
parallels its inhibitory activity in the release assay (EC
 
50
 
 
 
2–5 
 
 
 
M), consistent with a model in which C2A-C2B*
blocks fusion by competitively inhibiting native syt–SNARE
interactions.
Figure 2. Tandem C2A domains (C2A-
C2A) block syt–SNARE interactions and 
rapidly inhibit Ca
2 -triggered exocytosis. 
(A) Effect of syt constructs on the rate 
and extent of NE release. C2A-C2B ( ; 
G374 version) potently inhibits secre-
tion, presumably by blocking native syt 
oligomerization (Desai et al., 2000; 
Littleton et al., 2001). C2A-C2B* ( ), 
harbors a K326,327A mutation that 
disrupts the ability of the recombinant 
protein to bind native syt in the cracked 
cells (without causing misfolding; Desai 
et al., 2000). Although C2A-C2B* can-
not interfere with native syt oligomeriza-
tion (because it does not bind endoge-
nous syt in the cracked cells), this 
construct exhibits a second mode of 
inhibition that occurs at higher protein 
concentrations. C2A, which fails to bind 
SNAP-25, fails to inhibit secretion ( ). 
However, tethering two C2A domains 
together (C2A-C2A;  ) resulted in a 
chimeric protein with SNAP-25 binding 
activity (B) and inhibitory activity that 
were similar to C2A-C2B*. As a control, 
two Ca
2  ligands in each C2A domain 
were neutralized D230,232N, disrupting 
the Ca
2  binding activity of the protein 
(Zhang et al., 1998). C2A(D230,232N)-
C2A(D230,232N) binding to SNAREs 
was not detectable under our assay 
conditions (B), and this construct exhib-
ited reduced inhibitory activity ( ). Note 
the potency of inhibition of C2A-C2B ( ) and C2A-C2B* ( ) using this assay differs from a previous study using primed cells in which secre-
tion was monitored using 
3H-NE (Desai et al., 2000). The reason for this difference is not clear; however, in all experiments the rank order of 
inhibition by different inhibitors is the same between these two assay systems. Also note that to facilitate comparisons between the proteins 
used in this study, the ordinate is cut-off at 50% inhibition; at 10  M, C2A-C2B inhibited 80–90% of release. (B) Tethering two C2A domains 
together results in a t-SNARE binding protein. Binding assays were carried out as described in Davis et al. (1999) except that 30  g SNAP-25 
was immobilized on beads. Eight percent of bound proteins was subjected to SDS-PAGE and visualized by immunoblotting using ECL. As a 
positive control, C2A-C2B* was analyzed in parallel. This mutant form was used to avoid increases in bound material that occur as a result of 
Ca
2 -triggered syt homooligomerization (that is, the interaction of additional copies of syt with the syt that is bound to the SNAP-25 beads). 
As a further control, C2A(D230,232N)-C2A(D230,232N) was assayed for SNAP-25 binding activity. Standards are 10 ng C2A-C2B* and C2A-
C2A, and 5 ng C2A. (C) C2A-C2A displaces native syt from SNARE complexes. Experiments were carried out by immunoprecipitation of 
synaptobrevin. 1-ml aliquots of rat BDE (1 mg/ml; prepared as described in Chapman et al. [1996]) were incubated in either 2 mM EGTA or 
1 mM Ca
2  with the indicated concentrations of C2A-C2A for 1.5 h. SNARE complexes were immunoprecipitated with an antisynaptobrevin 
antibody (69.1; 10  L) for 1.5 h followed by addition of 60  l of protein G-Sepharose Fast Flow (Amersham Pharmacia Biotech) for 1 h. 
Immunoprecipitates were washed four times, and 20% of bound proteins was subjected to SDS-PAGE and visualized by ECL. Total corre-
sponds to 1  g BDE. Polyclonal antibodies were used to detect native syt (anti-C2B) and SNAP-25, and monoclonal antibodies were used to 
detect syntaxin, synaptobrevin, and C2A-C2A (anti-C2A). (D) Tethering two C2A domains together does not result in additional new protein–
protein interactions. These experiments were carried out as described in Chapman et al. (1998) but expanded to include SV2. To assay for 
SV2, 6  l of BDE (total) and 40% of the bound material was subjected to SDS-PAGE and immunoblotted using anti-SV2 antibodies. (E) Timing 
of inhibition. Addition of C2A-C2B* (final concentration 4  M) at the times indicated (arrows) inhibits release to a similar extent at all stages 
in the release process and does not require preincubation; addition of Ca
2  is indicated by the vertical lines. Identical results were obtained 
using C2A-C2A (unpublished data). 
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To test this hypothesis and to rule out the possibility that
the inhibitory activity was due to residual activity of the mu-
tant C2B domain of C2A-C2B*, we designed a selective in-
hibitor of syt–SNARE interactions. Because neither of the
isolated C2 domains of syt I efficiently binds SNAREs
(Chapman et al., 1996; Davis et al., 1999), we reasoned that
syt I acquired tandem C2 domains during evolution to regu-
late SNARE-mediated membrane fusion. This model pre-
dicts that a SNARE binding protein could be generated by
linking two C2 domains together for use as a selective inhib-
itor of native syt–SNARE interactions in cracked PC12
cells. A construct comprising tandem C2B domains would
be uninformative because C2B alone inhibits secretion,
again presumably via blocking syt oligomerization (Desai et
al., 2000). We therefore focused on C2A, which does not
block secretion (Fig. 2 A; note our data contrast those of El-
ferink et al. [1993], reporting inhibition by this fragment).
Tethering two C2A domains together (designated C2A-
C2A) resulted in a protein that inhibited secretion with a
potency similar to that of C2A-C2B* (Fig. 2 A). Further-
more, C2A-C2A bound to SNAP-25 with an affinity that
precisely mirrored its inhibitory activity in the release assay
(Fig. 2 B). As a further control, we neutralized Ca
 
2
 
 
 
 ligands
in both C2 domains of C2A-C2A (Sutton et al., 1995;
Zhang et al., 1998), which reduced both SNAP-25 binding
activity and inhibitory activity in the release assay.
 
These data are consistent with a model in which C2A-
C2A and C2A-C2B* inhibit fusion by blocking native syt–
SNARE interactions. This was tested directly by immu-
noprecipitating SNARE complexes from brain detergent
extracts (BDEs) in the presence of increasing concentrations
of C2A-C2A. SNARE complexes were isolated using an an-
tisynaptobrevin antibody. Syt does not bind directly to syn-
aptobrevin thus antisynaptobrevin immunoprecipitations
selectively pull-down syt that is bound to SNARE complexes
containing both v- and t-SNAREs. As shown in Fig. 2 C,
C2A-C2A blocked the binding of native syt to SNARE
complexes over precisely the same concentration range that
inhibits secretion. Furthermore, maximal inhibition of bind-
ing, 50%, coincides with the extent of inhibition observed
in the cracked cell assay.
These observations further suggest that inhibition by
C2A-C2A is mediated by Ca
2 -dependent binding to
SNAREs. Although we cannot rule out that C2A-C2A in-
hibits exocytosis by blocking other unknown interactions,
the following evidence argues against this possibility. First,
in Fig. 2 D C2A-C2A fails to bind the known syt binding
proteins AP-2 (Zhang et al., 1994), SV2 (Schivell et al.,
1996), and other copies of syt (Desai et al., 2000); synapto-
physin,   / -SNAP, and synaptobrevin served as negative
controls. Second, we have conducted an unbiased search for
proteins that bind C2A-C2A but not C2A using affinity
Figure 3. Partial functional and biochemi-
cal redundancy between Ca
2  ligands in C2A 
and C2B that regulate syt–t-SNARE interac-
tions. (A) Functional redundancy of the Ca
2  
ligands in the C2 domains of syt I (G374). The 
effects of Ca
2  ligand mutations on the ability 
C2A-C2B* to inhibit release was assayed as 
described in the legend to Fig. 2 A. Inhibition 
by C2A-C2B* is indicated by  . Inhibition 
was only partially abrogated by muta-
tions that disrupt Ca
2  binding to C2A 
(D230,232N;  ) or C2B (D363,365N;  ). 
However, inhibitory activity was largely abol-
ished by simultaneous disruption of the
Ca
2 -sensing ability of both C2A and C2B 
(D230,232,363,365N;  ). (B) Ca
2 -triggered 
t-SNARE binding activity of syt I (G374) and 
III exhibits redundancy between Ca
2  ligands 
in C2A and C2B. Binding assays were carried 
out as described in the legend to Fig. 2 B 
except the GST-syntaxin was 15  g. “Total” 
corresponds to 1% of the binding reaction. As 
described in the legend to Fig. 2 B, the aster-
isk indicates a mutation (K326,327A in syt I 
or R482A,K483A in syt III) that disrupts C2B-
mediated syt oligomerization (Desai et al., 
2000) to avoid increases in binding to 
t-SNARE beads that result from syt oligomer-
ization. (Top) In syt I (G374), disruption of the 
Ca
2 -sensing ability of either C2 domain
is partially tolerated (D230,232N or 
D363,365N); simultaneous neutralization
of Ca
2  ligands in both C2 domains 
(D230,232N,D363,365N) disrupts t-SNARE binding activity. (Middle) In syt I (D374), mutations that disrupt the Ca
2 -sensing ability of C2A 
(D230,232N) abolish SNARE binding activity, whereas mutations that disrupt the Ca
2 -sensing ability of C2B domain (D363,365N) have a 
lesser effect (Bai et al., 2000). (Bottom) Syt III exhibits Ca
2  ligand redundancy for SNARE binding activity analogous to syt I (G374). Simulta-
neous neutralization of Ca
2  ligands in both C2 domains (D385,387N and D519,521N) was required to disrupt Ca
2 -triggered SNARE bind-
ing activity.Disruption of synaptotagmin–SNARE interactions | Earles et al. 1121
chromatography. Both proteins bind several yet-to-be char-
acterized proteins from BDE, but the binding protein pro-
files for C2A and C2A-C2A were identical (unpublished
data; note that C2A-C2B and C2A-C2A cannot efficiently
bind SNAREs when fused to glutathione S-transferase and
immobilized on beads [Chapman et al., 1996]). Finally,
C2A binds with high affinity to acidic phospholipids (40
nM; Davis et al., 1999) as does C2A-C2A. Yet, C2A fails to
inhibit secretion. This result is not unexpected; even if
C2A–membrane interactions are critical for exocytosis, 10
 M C2A would not be expected to saturate all of the lipid
binding sites in the cracked cells. We conclude that the most
likely mode of inhibition by C2A-C2A is via blocking native
syt–SNARE interactions.
If these interactions have a critical role in a late step in se-
cretion, we would expect rapid inhibition regardless of the
time at which C2A-C2A was added to the cracked cells. Ad-
dition of C2A-C2B* (Fig. 2 E) or C2A-C2A (unpublished
data) before, during, or at varying times after the Ca
2  signal
resulted in the rapid inhibition of exocytosis, suggesting per-
turbation of a late step in the fusion reaction.
The ability of tethered C2A domains to bind t-SNAREs
further indicates a form of synergy between tandem C2 do-
mains (Chapman et al., 1996; Davis et al., 1999). We fur-
ther explored this synergy by disrupting the Ca
2  binding
ability of each C2 domain in C2A-C2B*; disruption of ei-
ther C2A or C2B only partially abrogated inhibitory activity
in the cracked cell assay (Fig. 3 A). However, simultaneous
disruption of both C2 domains strongly reduced inhibitory
activity (Fig. 3 A). The effects of these mutations in the re-
lease assay were paralleled by their effects on SNAREs bind-
ing activity (Fig. 3 B). Titration experiments indicated that
mutations within a single C2 domain reduce the affinity for
SNAP-25 by approximately twofold (unpublished data) and
shift the inhibitory activity of C2A-C2B* by roughly the
same factor (Fig. 3 A).
We note that earlier studies demonstrated that neutral-
ization of Ca
2  ligands in C2A blocked Ca
2 -triggered
t-SNARE and membrane interactions (Davis et al., 1999;
Bai et al., 2000). However, previous studies made use of the
initial syt I cDNA (Perin et al., 1990) that was shown re-
cently to harbor a mutation (D374) that disrupts the activity
of the C2B domain (Osborne et al., 1999; Desai et al.,
2000). Because all other known syt sequences harbor a gly-
cine at this position (G374), it is unclear whether the D374
variant is a bona fide version of syt I. In Fig. 3 B, we have
confirmed that mutations in the C2A domain of D374-syt I
indeed disrupt Ca
2 -triggered t-SNARE binding activity.
To test whether the apparent partial redundancy between
the Ca
2  ligands in the C2 domains of syt I (G374) occurs
with other isoforms, we generated analogous mutations in the
C2 domains of syt III; again, complete disruption of Ca
2 -
triggered t-SNARE binding activity required mutations in
both C2 domains (Fig. 3 B, bottom). We saw a similar re-
dundancy when Ca
2 -triggered liposome binding activity was
measured (Fig. 4, A and C). These findings suggested that
like C2A, the C2B domains of syt I (G374) and III may form
autonomous Ca
2 -triggered membrane binding domains.
We tested this possibility and found that the isolated C2B do-
mains fail to bind membranes in response to Ca
2  (Fig. 4 B).
Thus, an inactive C2A domain when tethered to an inactive
C2B domain gives rise to a protein with Ca
2 -triggered lipid
binding activity. These data suggest a novel form of coopera-
tion between tandem C2 domains. In one model, C2B can
compensate for Ca
2  ligand mutations in C2A such that the
lipid binding activity within C2A is restored. Alternatively,
an adjacent C2A domain may “activate” cryptic Ca
2 -trig-
Figure 4. Partial redundancy between Ca
2  ligands in C2A and 
C2B that regulate syt–membrane interactions. Wild-type and 
mutant forms of syt I and III were immobilized (0.1 nmole) on glu-
tathione–Sepharose beads. The isolated C2 domains of these 
isoforms were also analyzed. 
3H-labeled 25% PS/75% PC liposome 
binding assays were carried out as described (Bai et al., 2000). (A) In 
the G374 form of syt I (C2A-C2B), Ca
2 -triggered liposome binding 
activity is abolished only when Ca
2  ligands are simultaneously 
neutralized in both C2A and C2B (D230,232,363,365N). In the 
D374 form of syt I (C2A-C2B), Ca
2 -triggered liposome binding 
activity is abolished by mutations that neutralize Ca
2  ligands in the 
C2A domain (D230,232N; Bai et al., 2000). (B) C2A but not C2B 
derived from either G374 or D374 syt I forms an autonomous Ca
2 -
dependent lipid-binding module. (C) Syt III exhibits the same redun-
dancy as G374 syt I above; complete disruption of Ca
2 -triggered 
liposome binding activity required simultaneous neutralization of 
Ca
2  ligands in both C2 domains (D385,387N and D519,521N); 
the isolated C2B domain failed to bind membranes.1122 The Journal of Cell Biology | Volume 154, Number 6, 2001
gered membrane binding activity within C2B. Finally, as a
control we confirmed that mutations in the C2A domain of
the intact cytoplasmic domain of the D374 version of syt I
abolished lipid binding activity (Bai et al., 2000), further es-
tablishing that the atypical aspartate residue at position 374
disrupts the function of C2B (Desai et al., 2000).
The partial redundancy of the Ca
2  ligands in C2A and
C2B should be taken into account in reverse genetic studies.
For example, Ca
2  ligand mutations in the C2A domain of
Drosophila syt I appear to be tolerated (for review see Augus-
tine, 2001). This may be due to findings reported here; no
known overall function of syt I is completely disrupted by
Ca
2  ligand mutations that are restricted to the C2A do-
main. In contrast, disruption of the Ca
2 -sensing ability of
C2B is lethal (Littleton et al., 2001). These findings indicate
that it will be necessary to find mutations other than Ca
2 
ligand substitutions to selectively knockout Ca
2 -triggered
syt–SNARE interactions.
The data described here support a functional role for the
interaction of syt with SNAREs during Ca
2 -triggered exo-
cytosis. We do not yet know which of the numerous iso-
forms of syt expressed in PC12 cells (Marqueze et al., 2000)
regulate secretion. Since all syts that interact with SNAREs
are likely to bind via a common mechanism, the C2A-C2A
construct would be expected to compete with all endoge-
nous syts in the same way that it blocks syt I binding.
A current goal is to determine the mechanism by which
syt influences SNARE catalyzed membrane fusion. Syt binds
to the membrane proximal “base” of both t-SNAREs, syn-
taxin, and SNAP-25 at all stages of SNARE complex assem-
bly (Chapman et al., 1995; Davis et al., 1999; Sutton et al.,
1999; Gerona et al., 2000; Littleton et al., 2001). These in-
teractions occur in the absence of Ca
2 , but Ca
2  increases
their affinity by at least an order of magnitude. We propose
that the Ca
2 -independent mode of binding poises the re-
lease machinery for rapid responses to Ca
2  and that the
conformational changes associated with Ca
2 -induced in-
creases in affinity have a role in triggering the fusion reac-
tion, potentially by facilitating assembly of SNAREs into an
active state that may involve C2B-driven multimerization of
SNARE complexes (Desai et al., 2000; Littleton et al.,
2001). Recent studies also point to a critical role for the pen-
etration of the C2A domain into membranes (Davis et al.,
1999; Bai et al., 2000) in excitation-secretion coupling
(Fernández-Chacón et al., 2001). Thus, syt may also operate
by altering the physical relationship between the base of the
SNARE complex and lipid bilayers (Davis et al., 1999).
Materials and methods
Cell cracking
PC12 cells were grown and detached as described previously (Klenchin et
al., 1998). Detached cells were cracked by centrifugation at 1,600 g for 3
min ( 80% of the cells were cracked as determined by trypan blue stain-
ing), and the cell pellet was resuspended in Hepes release buffer ( 1 ml
per 10-cm dish). Cells were used before notable rundown and were not
primed for these experiments (Klenchin et al., 1998).
RDE voltammetry release assay 
Release profiles were generated by adding 350  l containing  10
7
cracked cells to the temperature-controlled incubation chamber (contain-
ing an Ag/AgCl reference and platinum auxiliary electrode) set to 37 C. A
glassy carbon RDE (Eapp    500 mV versus Ag/AgCl reference electrode)
was placed into the cell suspension and rotated at 3,000 rpm to maintain
the cells in rapidly mixing conditions. Once a stable baseline was ob-
served (usually within 2 min), a rapid pulse of Ca
2  was added to the sus-
pension via a Hamilton constant flow rate syringe. Ca
2  releases NE from
vesicular stores ( 10% of the total NE is released at 80 s in response to
100  M Ca
2 ), the released NE is oxidized at the surface of the RDE, and
the resulting current is converted to concentration using a standard curve.
The current at an RDE is directly proportional to the concentration of the
species being oxidized as defined by the Levich equation (Earles and
Schenk, 1998). The sensitivity of the RDE assay made it unnecessary to
preload PC12 cells with NE.
Analysis of release curves
Release curves were background subtracted to eliminate slight signal drops
due to addition of Ca
2 . Corrected curves were well fitted by single expo-
nential functions, yielding the time constants and amplitudes of response
(Axograph software). The reciprocal of the time constant was plotted ver-
sus Ca
2  to determine the [Ca
2 ]1/2. For inhibition experiments, the percent
of inhibition was calculated by comparing initial rates or amplitudes of re-
lease profiles generated in the presence and absence of inhibitor. Initial
rates were calculated from the slope of a tangent line fitted to the initial
linear portion of the release profile. Amplitudes correspond to the cumula-
tive amount of NE released 80 s after the addition of Ca
2 .
Recombinant proteins 
cDNA encoding rat syt I (D374, Perin et al., 1990; G374, Osborne et al.,
1999), rat syt III (Mizuta et al., 1994), human SNAP-25B (Bark and Wilson,
1994), and rat syntaxin 1A (Bennett et al., 1992) were provided by T. Süd-
hof (Howard Hughes Medical Institute, Dallas, TX), G. Schiavo (Imperial
Cancer Research Fund, London, UK), S. Seino (Chiba University, Chiba,
Japan), R. Scheller (Genentech, Inc., Stanford, CA), and M. Wilson (Uni-
versity of New Mexico, Albuquerque, NM), respectively.
The cytoplasmic (residues 96–421), C2A (residues 96–265), and C2B
(residues 248–421) domains of wild-type and mutant versions of syt I
(G374 and D374 versions) were prepared as described (Chapman et al.,
1995). C2A-C2A subcloned into pGEX 4T-1 via Bam H1-Sal 1 sites is com-
posed of the C2A domain with the linker region (96–272) (Sutton et al.,
1999) followed by a two amino acid insert (Glu-Leu) and a second C2A
domain (142–265). The cytoplasmic (residues 290–569), the C2A (residues
290–420), and the C2B (residues 421–569) domains of rat syt III and the
indicated point mutations were generated from the sequence reported by
Mizuta et al. (1994) and subcloned via EcoR1 and Xho1 sites into pGEX-
4T-1. All recombinant constructs were confirmed by DNA sequencing and
expressed and purified as described; soluble syt fragments were prepared
by thrombin cleavage of glutathione S-transferase fusion proteins (Chap-
man et al., 1996).
Immunoprecipitation and antibodies
Mouse monoclonal antibodies directed against rat syt I (41.1 and 604.1),
syntaxin (HPC-1), synaptobrevin (69.1), SV2 (7G8-IgG), synaptophysin
(7.2), and  / -SNAP (77.1) were provided by S. Engers and R. Jahn (Max-
Planck Institute, Göttingen, Germany). The AP-2 antibody (anti– -adaptin;
100/2) was from Sigma-Aldrich. Polyclonal rabbit antibodies generated to
the C2B regions of syt I were provided by T.F.J. Martin (University of Wis-
consin, Madison, WI); rabbit antibodies directed against the COOH-termi-
nal SNAP25 peptide (residues 195–206) were obtained from StressGen
Biotechnologies.
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